228 related articles for article (PubMed ID: 14994974)
1. Voriconazole for serious fungal infections.
Gothard P; Rogers TR
Int J Clin Pract; 2004 Jan; 58(1):74-80. PubMed ID: 14994974
[TBL] [Abstract][Full Text] [Related]
2. Voriconazole: a new triazole antifungal.
Sabo JA; Abdel-Rahman SM
Ann Pharmacother; 2000 Sep; 34(9):1032-43. PubMed ID: 10981251
[TBL] [Abstract][Full Text] [Related]
3. Voriconazole : a review of its use in the management of invasive fungal infections.
Scott LJ; Simpson D
Drugs; 2007; 67(2):269-98. PubMed ID: 17284090
[TBL] [Abstract][Full Text] [Related]
4. Voriconazole: therapeutic review of a new azole antifungal.
Herbrecht R
Expert Rev Anti Infect Ther; 2004 Aug; 2(4):485-97. PubMed ID: 15482215
[TBL] [Abstract][Full Text] [Related]
5. Voriconazole: a new triazole antifungal agent.
Pearson MM; Rogers PD; Cleary JD; Chapman SW
Ann Pharmacother; 2003 Mar; 37(3):420-32. PubMed ID: 12639175
[TBL] [Abstract][Full Text] [Related]
6. Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia.
Jørgensen KJ; Gøtzsche PC; Dalbøge CS; Johansen HK
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD004707. PubMed ID: 24563222
[TBL] [Abstract][Full Text] [Related]
7. Voriconazole: a broad-spectrum triazole for the treatment of invasive fungal infections.
Cecil JA; Wenzel RP
Expert Rev Hematol; 2009 Jun; 2(3):237-54. PubMed ID: 21082966
[TBL] [Abstract][Full Text] [Related]
8. [Voriconazole: a new weapon against invasive fungal infections].
Aoun M
Rev Med Brux; 2004 Jun; 25(3):166-71. PubMed ID: 15291449
[TBL] [Abstract][Full Text] [Related]
9. Voriconazole: a new triazole antifungal agent.
Johnson LB; Kauffman CA
Clin Infect Dis; 2003 Mar; 36(5):630-7. PubMed ID: 12594645
[TBL] [Abstract][Full Text] [Related]
10. Voriconazole -- better chances for patients with invasive mycoses.
Ghannoum MA; Kuhn DM
Eur J Med Res; 2002 May; 7(5):242-56. PubMed ID: 12069915
[TBL] [Abstract][Full Text] [Related]
11. [symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections.
Drug Ther Bull; 2004 Jan; 42(1):5-8. PubMed ID: 14768298
[TBL] [Abstract][Full Text] [Related]
12. Voriconazole versus amphotericin B in cancer patients with neutropenia.
Jørgensen KJ; Gøtzsche PC; Johansen HK
Cochrane Database Syst Rev; 2006 Jan; (1):CD004707. PubMed ID: 16437492
[TBL] [Abstract][Full Text] [Related]
13. Voriconazole.
Jeu L; Piacenti FJ; Lyakhovetskiy AG; Fung HB
Clin Ther; 2003 May; 25(5):1321-81. PubMed ID: 12867215
[TBL] [Abstract][Full Text] [Related]
14. [In vitro antifungal activity of voriconazole: New data after the first years of clinical experience].
Quindós G; Carrillo-Muñoz AJ; Eraso E; Cantón E; Pemán J
Rev Iberoam Micol; 2007 Sep; 24(3):198-208. PubMed ID: 17874856
[TBL] [Abstract][Full Text] [Related]
15. Review of the safety and efficacy of voriconazole.
Hoffman HL; Rathbun RC
Expert Opin Investig Drugs; 2002 Mar; 11(3):409-29. PubMed ID: 11866669
[TBL] [Abstract][Full Text] [Related]
16. Voriconazole: review of a broad spectrum triazole antifungal agent.
Kofla G; Ruhnke M
Expert Opin Pharmacother; 2005 Jun; 6(7):1215-29. PubMed ID: 15957974
[TBL] [Abstract][Full Text] [Related]
17. [The role of voriconazole in the treatment of emerging mycoses].
Pastor FJ; Guarro J
Rev Iberoam Micol; 2007 Sep; 24(3):228-32. PubMed ID: 17874861
[TBL] [Abstract][Full Text] [Related]
18. Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed.
Prescrire Int; 2004 Feb; 13(69):13-6. PubMed ID: 15055210
[TBL] [Abstract][Full Text] [Related]
19. Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model.
Ghannoum MA; Okogbule-Wonodi I; Bhat N; Sanati H
J Chemother; 1999 Feb; 11(1):34-9. PubMed ID: 10078778
[TBL] [Abstract][Full Text] [Related]
20. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]